⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Pomerantz LLP Notifies Investors of Class Action Lawsuit Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
prnewswire.com
SPRY
Pomerantz LLP Notifies Investors of Class Action Filing Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bronstein, Gewirtz & Grossman Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY